Litcius/Paper detail

Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis

Niveditha Devasenapathy, A. Chu, Melanie Wong, Archita Srivastava, Renata Ceccacci, Clement Lin, Margaret MacDonald, Aaron Wen, Jeremy Steen, Mitchell Levine, Lonnie Pyne, Lynda C. Schneider, Derek K. Chu, Rachel Netahe Asiniwasis, Mark Boguniewicz, Renata Ceccacci, Lina Chen, Alexandro Chu, Derek K Chu, Anna De Benedetto, Niveditha Devasenapathy, Winfred T Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mitchell Levine, Clement Lin, Mary Laura Lind, Peter A Lio, Margaret MacDonald, Stephen A Martin, Monica O'Brien, Peck Y Ong, Lonnie Pyne, Lynda Schneider, Jonathan I Silverberg, Jonathan M Spergel, Archita Srivastava, Jeremy Steen, Julie Wang, Aaron Wen, Melanie Wong

2022The Lancet Child & Adolescent Health83 citationsDOI

Topics & Concepts

PimecrolimusCalcineurinTacrolimusAtopic dermatitisDermatologyMedicineMeta-analysisSkin cancerCancerInternal medicineTransplantationDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAsthma and respiratory diseases